Status:
COMPLETED
Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).
Lead Sponsor:
Pfizer
Conditions:
Urinary Bladder, Overactive
Eligibility:
All Genders
Brief Summary
The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in thi...
Detailed Description
All the patients whom an investigator prescribes the first Detrusitol® Capsule should be registered consecutively until the number of subjects reaches target number in order to extract patients enroll...
Eligibility Criteria
Inclusion
- Patients need to be administered Detrusitol® Capsule in order to be enrolled in the surveillance.
Exclusion
- Patients not administered Detrusitol® Capsule.
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
374 Patients enrolled
Trial Details
Trial ID
NCT00795509
Start Date
August 1 2007
End Date
March 1 2011
Last Update
July 9 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.